LAB
LAB
NASDAQ · Life Sciences Tools & Services

Standard Biotools Inc

$0.77
+0.04 (+5.45%)
As of Sep 20, 10:26 PM ET ·
Financial Highlights (FY 2026)
Revenue
86.28M
Net Income
-75,743,129
Gross Margin
49.9%
Profit Margin
-87.8%
Rev Growth
-4.5%
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 49.9% 49.9% 33.5% 33.5%
Operating Margin -129.2% -116.3% 10.2% 9.7%
Profit Margin -87.8% -83.4% 8.2% 10.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 86.28M 90.32M 337.87M 394.49M
Gross Profit 43.02M 45.04M 113.16M 132.12M
Operating Income -111,469,809 -105,028,086 34.61M 38.43M
Net Income -75,743,129 -71,366,013 27.76M 42.76M
Gross Margin 49.9% 49.9% 33.5% 33.5%
Operating Margin -129.2% -116.3% 10.2% 9.7%
Profit Margin -87.8% -83.4% 8.2% 10.8%
Rev Growth -4.5% -4.5% +3.9% -1.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 82.4K 82.4K 57.07M 49.88M
Total Equity 137.32M 137.32M 239.14M 240.02M
D/E Ratio 0.00 0.00 0.24 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -102,096,953 -101,541,148 49.10M 55.88M
Free Cash Flow 19.25M 25.05M